Recalls and Safety Alerts: New Warnings in Labeling for Clorazil
Published by Food and Drug Adminstration (FDA): Patient Safety March 31st, 2006 in Patient Safety, Regulatory AffairsNovartis has notified healthcare professionals about new warnings and drug information in the labeling for the antipsychotic drug Clozaril (clozapine).
Patients taking clozapine are at increased risk of potentially life-threatening agranulocytosi…